Literature DB >> 30775027

Circulating tumor cells (CTCs) for the noninvasive monitoring and personalization of non-small cell lung cancer (NSCLC) therapies.

Patrycja Pawlikowska1,2, Vincent Faugeroux1,2, Marianne Oulhen2, Agathe Aberlenc2, Tala Tayoun1,2, Emma Pailler1,2, Françoise Farace1,2.   

Abstract

Growing evidences for tumor heterogeneity confirm that single-tumor biopsies frequently fail to reveal the widespread mutagenic profile of tumor. Repeated biopsies are in most cases unfeasible, especially in advanced cancers. We describe here how circulating tumor cells (CTCs) isolated from minimally invasive blood sample might inform us about intratumor heterogeneity, tumor evolution and treatment resistance. We also discuss the advances of CTCs research, most notably in molecularly selected non-small cell lung cancer (NSCLC) patients, highlighting challenges and opportunities related to personalized therapy.

Entities:  

Keywords:  Circulating tumor cells (CTC); liquid biopsy; non-small cell lung cancer (NSCLC)

Year:  2019        PMID： 30775027      PMCID： PMC6353742          DOI： 10.21037/jtd.2018.12.80

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


  10 in total

1.  Does GD2 synthase (GD2S) detect cancer stem cells in blood samples of breast carcinomas?

Authors:  Maryam Mansoori; Isa Abdi Rad; Alireza Mirzaei; Kevin J Tam; Seyed Mohsen Hosseini; Rahim Mahmodlu; Fatemeh Mansouri; Leili Saeednejad Zanjani; Zahra Madjd
Journal:  J Appl Biomed       Date:  2021-09-16       Impact factor: 1.797

2.  High throughput, label-free isolation of circulating tumor cell clusters in meshed microwells.

Authors:  Mert Boya; Tevhide Ozkaya-Ahmadov; Brandi E Swain; Chia-Heng Chu; Norh Asmare; Ozgun Civelekoglu; Ruxiu Liu; Dohwan Lee; Sherry Tobia; Shweta Biliya; L DeEtte McDonald; Bassel Nazha; Omer Kucuk; Martin G Sanda; Benedict B Benigno; Carlos S Moreno; Mehmet A Bilen; John F McDonald; A Fatih Sarioglu
Journal:  Nat Commun       Date:  2022-06-13       Impact factor: 17.694

3.  Evaluation of Monocarboxylate Transporter 4 (MCT4) Expression and Its Prognostic Significance in Circulating Tumor Cells From Patients With Early Stage Non-Small-Cell Lung Cancer.

Authors:  Athina Markou; E Tzanikou; G Kallergi; E Pantazaka; V Georgoulias; A Kotsakis; E Lianidou
Journal:  Front Cell Dev Biol       Date:  2021-04-22

4.  Clinical significance of circulating tumor cells and metabolic signatures in lung cancer after surgical removal.

Authors:  Dawei Yang; Xiaofang Yang; Yang Li; Peige Zhao; Rao Fu; Tianying Ren; Ping Hu; Yaping Wu; Hongjun Yang; Na Guo
Journal:  J Transl Med       Date:  2020-06-17       Impact factor: 5.531

5.  Capture and Detection of Circulating Glioma Cells Using the Recombinant VAR2CSA Malaria Protein.

Authors:  Sara R Bang-Christensen; Rasmus S Pedersen; Marina A Pereira; Thomas M Clausen; Caroline Løppke; Nicolai T Sand; Theresa D Ahrens; Amalie M Jørgensen; Yi Chieh Lim; Louise Goksøyr; Swati Choudhary; Tobias Gustavsson; Robert Dagil; Mads Daugaard; Adam F Sander; Mathias H Torp; Max Søgaard; Thor G Theander; Olga Østrup; Ulrik Lassen; Petra Hamerlik; Ali Salanti; Mette Ø Agerbæk
Journal:  Cells       Date:  2019-08-28       Impact factor: 6.600

6.  Circulating Tumor Cells Counting Act as a Potential Prognostic Factor in Cervical Cancer.

Authors:  Kunpeng Du; Qian Huang; Junguo Bu; Jieling Zhou; Zijian Huang; Jiqiang Li
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec

7.  Gene expression in circulating tumor cells reveals a dynamic role of EMT and PD-L1 during osimertinib treatment in NSCLC patients.

Authors:  Aliki Ntzifa; Areti Strati; Galatea Kallergi; Athanasios Kotsakis; Vassilis Georgoulias; Evi Lianidou
Journal:  Sci Rep       Date:  2021-01-27       Impact factor: 4.379

Review 8.  Detecting Resistance to Therapeutic ALK Inhibitors in Tumor Tissue and Liquid Biopsy Markers: An Update to a Clinical Routine Practice.

Authors:  Paul Hofman
Journal:  Cells       Date:  2021-01-15       Impact factor: 6.600

9.  Circulating tumour cells and circulating cell-free DNA in patients with lung cancer: a comparison between thoracotomy and video-assisted thoracoscopic surgery.

Authors:  Periklis Katopodis; Vladimir Anikin; Uday Kishore; Thomas Carter; Marcia Hall; Nizar Asadi; Andreas Polychronis; Emmanouil Karteris
Journal:  BMJ Open Respir Res       Date:  2021-09

10.  Identification of plasma exosomes long non-coding RNA HAGLR and circulating tumor cells as potential prognosis biomarkers in non-small cell lung cancer.

Authors:  Le Rao; Lihua Luo; Liufang Luo; Shan Chen; Ruizhi Ran; Xianling Liu
Journal:  Transl Cancer Res       Date:  2019-10       Impact factor: 1.241
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.